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Abstract Purpose:
This study was designed to determine the role of laparoscopic adrenalectomy (LA) in the surgical
management of adrenocortical carcinoma (ACC).
Methods:
A systematic literature review was performed on January 2, 2015 using PubMed. Article selection
proceeded according to PRISMA criteria. Studies comparing open adrenalectomy (OA) to LA for ACC
and including at least 10 cases per each surgical approach were included. Odds ratio (OR) was used for all
binary variables, and weight mean difference (WMD) was used for the continuous parameters. Pooled
estimates were calculated with the fixed-effect model, if no significant heterogeneity was identified;
alternatively, the random-effect model was used when significant heterogeneity was detected. Main
demographics, surgical outcomes, and oncological outcomes were analyzed.
Results:
Nine studies published between 2010 and 2014 were deemed eligible and included in the analysis, all of
them being retrospective case–control studies. Overall, they included 240 LA and 557 OA cases. Tumors
treated with laparoscopy were significantly smaller in size (WMD −3.41 cm; confidence interval [CI]
−4.91, −1.91; p < 0.001), and a higher proportion of them (80.8 %) more at a localized (I–II) stage
compared with open surgery (67.7 %) (odds ratio [OR] 2.8; CI 1.8, 4.2; p < 0.001). Hospitalization time
was in favor of laparoscopy, with a WMD of −2.5 days (CI −3.3, −1.7; p < 0.001). There was no difference
in the overall recurrence rate between LA and OA (relative risk [RR] 1.09; CI 0.83, 1.43; p = 0.53),
whereas development of peritoneal carcinomatosis was higher for LA (RR 2.39; CI 1.41, 4.04; p = 0.001).
No difference could be found for time to recurrence (WMD −8.2 months; CI −18.2, 1.7; p = 0.11), as well
as for cancer specific mortality (OR 0.68; CI 0.44, 1.05; p = 0.08).
Conclusions:
OA should still be considered the standard surgical management of ACC. LA can offer a shorter hospital
stay and possibly a faster recovery. Therefore, this minimally invasive approach can certainly play a role in
this setting, but it should be only offered in carefully selected cases to avoid jeopardizing the oncological
outcome.
Footnote Information On the behalf of Italian Endourological Association (IEA) Research Office and International Translational
Research in Uro-Sciences Team (ITRUST).
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16 ABSTRACT
17 Purpose. This study was designed to determine the role of
18 laparoscopic adrenalectomy (LA) in the surgical manage-
19 ment of adrenocortical carcinoma (ACC).
20 Methods. A systematic literature review was performed
21 on January 2, 2015 using PubMed. Article selection pro-
22 ceeded according to PRISMA criteria. Studies comparing
23 open adrenalectomy (OA) to LA for ACC and including at
24 least 10 cases per each surgical approach were included.
25 Odds ratio (OR) was used for all binary variables, and
26 weight mean difference (WMD) was used for the contin-
27 uous parameters. Pooled estimates were calculated with the
28 fixed-effect model, if no significant heterogeneity was
29 identified; alternatively, the random-effect model was used
30 when significant heterogeneity was detected. Main demo-
31 graphics, surgical outcomes, and oncological outcomes
32 were analyzed.
33 Results. Nine studies published between 2010 and 2014were
34 deemed eligible and included in the analysis, all of them being
35retrospective case–control studies. Overall, they included 240
36LA and 557 OA cases. Tumors treated with laparoscopy were
37significantly smaller in size (WMD -3.41 cm; confidence
38interval [CI] -4.91, -1.91; p\0.001), and a higher propor-
39tion of them(80.8 %)more at a localized (I–II) stage compared
40with open surgery (67.7 %) (odds ratio [OR] 2.8; CI 1.8, 4.2;
41p\0.001). Hospitalization time was in favor of laparoscopy,
42with aWMDof-2.5 days (CI-3.3,-1.7; p\0.001). There
43was no difference in the overall recurrence rate between LA
44and OA (relative risk [RR] 1.09; CI 0.83, 1.43; p = 0.53),
45whereas development of peritoneal carcinomatosis was higher
46for LA (RR 2.39; CI 1.41, 4.04; p = 0.001). No difference
47could be found for time to recurrence (WMD-8.2 months; CI
48-18.2, 1.7; p = 0.11), as well as for cancer specific mortality
49(OR 0.68; CI 0.44, 1.05; p = 0.08).
50Conclusions. OA should still be considered the standard
51surgical management of ACC. LA can offer a shorter
52hospital stay and possibly a faster recovery. Therefore, this
53minimally invasive approach can certainly play a role in
54this setting, but it should be only offered in carefully
55selected cases to avoid jeopardizing the oncological
56outcome.
57
58
59Adrenocortical carcinoma (ACC) represents a rare but
60rather aggressive tumor,1 often associated with poor
61prognosis, despite aggressive multimodality treatment.2
62Surgical resection has traditionally been paying a major
63role in the management of the disease, especially in its
64early stages, where there might still be a window for cure.3
A1 On the behalf of Italian Endourological Association (IEA) Research
A2 Office and International Translational Research in Uro-Sciences
A3 Team (ITRUST).
A4  Society of Surgical Oncology 2015
A5 First Received: 25 May 2015
A6 R. Autorino, MD, PhD
A7 e-mail: ricautor@gmail.com;
riccardo.autorino@UHhospitals.org
AQ1
AQ2
AQ3
AQ4
Journal : Large 10434 Dispatch : 14-10-2015 Pages : 8
Article No. : 4900
h LE h TYPESET
MS Code : ASO-2015-08-1475 h CP h DISK4 4
Ann Surg Oncol
DOI 10.1245/s10434-015-4900-x
A
u
th
o
r
 P
r
o
o
f
U
N
C
O
R
R
E
C
T
E
D
P
R
O
O
F
65 Laparoscopic adrenalectomy was first reported by Gagner
66 et al. 1992 and since then rapidly implemented for the
67 resection of functioning and non functioning adrenal
68 masses, given the recognized advantages in terms of
69 postoperative morbidity and hospital stay compared with
70 open surgery.4–6 More recently, the role of robot-assisted
71 laparoscopy has been postulated for adrenal surgery.7
72 Laparoscopic surgery for malignant adrenal tumors also
73 has been explored, but its role remains highly debated, given
74 concerns regarding the quality of surgical resection and
75 related oncological risks.8–10 In case of ACC, several
76 laparoscopic series have been reported, with conflicting
77 results. According to contemporary guidelines open surgery
78 should be regarded as the standard treatment of patients with
79 localized (stage I–II)/locally advanced (stage III) ACC,
80 whereas laparoscopic adrenalectomy can be pursued in
81 selected patients with small ACCs (\8 cm) without preop-
82 erative evidence for invasiveness. Moreover, this technique
83 should be ideally performed in centers with a consolidated
84 experience in laparoscopic adrenal surgery.11,12
85 The goal of this study was to provide a systematic
86 review and meta-analysis of available comparative studies
87 assessing laparoscopic adrenalectomy (LA) versus open
88 adrenalectomy (OA) for the surgical resection of ACC.
89 METHODS
90 Literature Search and Studies Selection
91 A computerized systematic literature search was per-
92 formed by using the PubMed database to identify studies
93 published as of January 2, 2015. The following search free
94 text terms were used: ‘‘laparoscopic adrenalectomy’’ OR
95 ‘‘adrenocortical carcinoma.’’ Only studies that meet the
96 following eligibility criteria were included: original study,
97 comparing OA to LA for the specific indication ACC,
98 including at least 10 cases per study group, and allowing data
99 extraction of relevant outcomes. Identification and selection
100 of the studies was conducted according to Preferred Report-
101 ing Items for Systematic Reviews and Meta-analysis criteria
102 (www.prisma-statement.org). All titles were screened for
103 manuscripts written in the English language, and only on
104 adult patients. Titles of articles were first reviewed to ascer-
105 tain whether they might potentially fit the inclusion criteria.
106 After assessing the abstract, a more thorough subsequent
107 assessment was performed by looking at full text.
108 Study Quality Assessment
109 Because none of them was a randomized controlled trial,
110 the methodological quality of the studies was rated
111 according the Newcastle–Ottawa Scale (NOS) for
112observational retrospective studies.13 The level of evidence
113was reported as described by the Oxford Center for Evi-
114dence-Based Medicine.14
115Outcomes of Interest
116The following relevant parameters were assessed:
117demographics, including patients’ age, tumor characteris-
118tics (clinical presentation, size, stage, Weiss score 15);
119surgical outcomes (operative time, postoperative major
120(Clavien grade [2) complication rate, hospital stay, R0
121surgical margins status, use of adjuvant therapy—defined
122as any form of adjuvant therapy, such as chemotherapy,
123mitotane, radiation therapy), and oncological outcomes
124(rate of recurrence—defined as clinical, laboratory, or
125radiologic evidence of disease recurrence; time to recur-
126rence—defined as the time between surgery and occurrence
127of disease recurrence; rate of cancer specific mortality—
128defined as number of deaths, with cancer as the underlying
129cause of death, occurring in the study population during the
130follow-up period).
131Statistical Analysis
132A meta-analysis of extractable data was performed.
133Odds ratio (OR) was used for all binary variables, and
134weight mean difference (WMD) was used for the contin-
135uous parameters. For the studies presenting continuous data
136as means and range, estimated standard deviations were
137calculated using the methodology described by Hozo
138et al.15 Pooled estimates were calculated with the fixed-
139effect model (Mantel–Haenszel method), if no significant
140heterogeneity was identified; alternatively, the random-ef-
141fect model (DerSimonian–Laird method) was used when
142significant heterogeneity was detected.16,17 The final
143pooled effects were reported by the z test, and p\ 0.05
144was considered as statistically significant. To assess the
145heterogeneity among the included studies, the Cochrane v2
146test and inconsistency (I2) were used. Evaluation of
147potential publication bias was done by funnel plots analysis
148for each outcome. The data analysis was performed using
149the Review Manager software (Revman v.5.2.8, Cochrane
150Collaboration, Oxford, UK).
151RESULTS
152The initial search yielded 2070 and 2566 records, whose
153titles were screened. After initial screening and removal of
154duplicates, 24 articles were considered and reviewed based
155on title and abstract. At the end of the process, nine studies
156were reviewed in full text and confirmed to meet eligibility
157criteria (Fig. 1).18–26
AQ5
R. Autorino et al.
Journal : Large 10434 Dispatch : 14-10-2015 Pages : 8
Article No. : 4900
h LE h TYPESET
MS Code : ASO-2015-08-1475 h CP h DISK4 4
A
u
th
o
r
 P
r
o
o
f
U
N
C
O
R
R
E
C
T
E
D
P
R
O
O
F
158 An overview of the studies, all published between 2010
159 and 2014, is provided in Table 1. Overall, the quality of
160 studies was high, despite all being retrospective case–
161 control studies with a low level of evidence.
162 Demographics
163 Patients undergoing OA were older than those submitted
164 to LA (WMD 2.56 years; CI 0.78, 4.34; p = 0.005). In four
165 studies the clinical presentation of the adrenal tumor was
166 described, and a higher rate of incidentalomas was found in
167 the LA group (43 %) versus the OA group (31.8 %) (OR
168 2.39; CI 1.39, 4.12; p = 0.002).18,20,21,24 Tumors treated
169with laparoscopy were significantly smaller in size (WMD
170-3.41 cm; CI -4.91, -1.91; p\ 0.001), and a higher pro-
171portion of them (80.8 %) more at a localized (I–II) stage
172compared to open surgery (67.7 %) (OR 2.8; CI 1.8, 4.2;
173p\ 0.001). The Weiss score, which was available in four
174studies only, was similar between the two groups (WMD
175-0.01, CI -0.27, 0.25; p = 0.95).18,20,23,26
176Surgical Outcomes
177Data related to operative time were available for analysis
178in three studies, and no difference could be detected between
179the two techniques (p = 0.85).21,23,24 EBL was reported in
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Hits: n=2070
Studies NOT meeting eligibility criteria (original 
comparative studies, in english, done in human, indication: 
adrenocortical carcinoma) on the basis of the title only
Eligible studies (based on the title, after removing duplications): n=24
PubMed search
Date: Jan 2
nd
2015
Search term: “laparoscopic adrenalectomy”
Studies deemed not eligible on the basis of the abstract: n=15
Studies confirmed to eligible on full text assessment
and included in the analysis: n=9
PubMed search
Date: Jan 2
nd
2015
Search term: “adrenocortical carcinoma”
Hits: n=2566
n=2550n=2046
FIG. 1 PRISMA flow diagram
illustrating the study selection
process
TABLE 1 Characteristics and quality assessment of the included studies
Study Study
period
No. of cases
(OA:LA)
Tumor stage Study design Level of
evidencea
Quality
scoreb
Porpiglia 18 2002–2008 25:18 I/II only Retrospective case control 4 8/9
Miller 19 2003–2008 71:17 I–III Retrospective case control 4 8/9
Brix 20 1996–2009 117:35 I–III Retrospective case control 4 9/9
Lombardi 21 2003–2010 126:30 I–II Retrospective case control 4 8/9
Miller 22 2005–2011 110:46 I–III Retrospective case control 4 8/9
Mir 23 1993–2011 26:18 I–IV Retrospective case control 4 8/9
Fossa 24 1998–2011 15:17 I–III Retrospective case control 4 8/9
Cooper 25 1993–2012 46:46 I–IV Retrospective case control 4 8/9
Donatini 26 1985–2011 21:13 I/II only Retrospective case control 4 8/9
OA open adrenalectomy, LA laparosocpic adrenalectomy
a Oxford criteria
b Newcastle–Ottawa scale
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180 two studies only, and no difference could be detected
181 (p = 0.48; Fig. 2).23,24 Postoperative complication rate was
182 available in four studies, and, again, there was no difference
183 between laparoscopy and open surgery (p = 0.14).21,23,24,26
184 In the same four studies, the hospitalization time was repor-
185 ted, and this was consistently in favor of laparoscopy, with a
186 WMD of -2.5 days (CI -3.3, -1.7; p\ 0.001).21,23,24,26
187 There was no difference in the rate of negative surgical
188 margins (R0), which was reported in seven of the studies
189 (61.9 % for LA, 57.6 % for OA; p = 0.98).19,20,22–26 Adju-
190 vant therapy was used in a similar proportion of cases for LA
191 and OA (32.5 and 29.8 %, respectively; p = 0.91).20,21,23,25
192 The funnel plots suggested no publication bias, so that
193 heterogeneity is most likely explained by other differences
194 between the studies, such as study design, patient selection,
195 and outcome assessment.
196 Oncological Outcomes
197 There was no difference in the overall recurrence rate
198 between LA and OA (RR 1.09; CI 0.83, 1.43; p = 0.53;
199Fig. 3).18–26 In five studies, investigators looked at the
200development of peritoneal carcinomatosis at the time of
201recurrence, and there was an overall higher risk for LA
202versus OA (RR 2.39; CI 1.41, 4.04; p = 0.001).19,20,23–25
203Time to recurrence was reported in four studies only,
204and, also for this outcome, no significant difference could
205be detected between LA and OA (WMD -8.2 months; CI
206-18.2, 1.7; p = 0.11).19,21–23 Cancer-specific mortality
207was available for analysis in six of the studies, and, again,
208no significant difference was found (OR 0.68; CI 0.44,
2091.05; p = 0.08).18,20,21,23,25, 26 Also for these outcomes,
210the funnel plots suggested no publication bias, but rather
211heterogeneity related to other confounders related to study
212design.
213DISCUSSION
214An appropriate surgical resection is a mandatory step in
215the therapeutic management of ACC. Thus, the role of
216minimally invasive surgery for this specific indication is
217still under scrutiny, as data supporting its implementation
a. Operative time
c. Postoperative complication rate
b. EBL
d. Hospital stay
Study or Subgroup
Study or Subgroup
Study or Subgroup Mean MeanSD Total
LA OA Mean Difference Mean Difference
SD Total Weight IV, Fixed, 95% CI IV, Fixed, 95% CIYear
Lombardi 2012 5.3 9.33.7 30 6.2 126 21.7% -4.00 [-5.71, 2.29] 2012
Fossa 2013 10.5 15.27.5 17 6 15 2.9% -4.70 [-9.38, -0.02] 2013
Mir 2013 4 61.4 18 1.8 26 70.8% -2.00 [-2.95, -1.05] 2013
Donatini 2014 7 95 13 6 21 4.5% -2.00 [-5.74, 1.74]
Total (95% CI) 78 188 100.0% -2.51 [-3.31, -1.72]
2014
Fossa 2013
Lombardi 2012
Mir 2013
Heterogeneity: Chi2 = 7.42, df = 2 (P = 0.02); I2 = 73%
Test for overall effect: Z = 0.19 (P = 0.85)
Heterogeneity: Tau2 = 5.24, Chi2 = 18.45, df = 1 (P < 0.0001); I2 = 95%
Test for overall effect: Z = 0.71 (P = 0.48)
Heterogeneity: Chi2 = 0.37, df = 3 (P = 0.95); I2 = 0%
Test for overall effect: Z = 1.49 (P = 0.14)
Heterogeneity: Chi2 = 4.94, df = 3 (P = 0.18); I2 = 39%
Test for overall effect: Z = 6.18 (P < 0.00001)
179
135
297.5
87
65
78
17
30
18
241
129
272.5
52
54
78
15
126
26
167
16.9%
64.6%
18.5%
-62.00 [-111.02, -12.98]
6.00 [-19.10, 31.10]
-100 -50
Favours LA Favours OA
Favours LA Favours OA
Favours LA Favours OA
Favours LA Favours OA
0
-10
0.01
-10 -5 0 5 10
0.1 1 10 100
-5 0 5 10
50 100
-100
50
40
30
20
10
0 SE(MD)
-50 0 50 100
MD
-10
0.01
-10
5
4
3
2
1
0 SE(MD)
-5 0 5 10
MD
2
1.5
1
0.5
0 SE(log[OR])
0.1 1 10 100
OR
1
0.8
0.6
0.4
0.2
0 SE(MD)
-5 0 5 10
MD
25.00 [-21.88, 71.88]
Mir 2013 1.5 0.44 18 1.1 0.61 26 52.5% 0.40 [0.09, 0.71] 2013
Fossa 2013 0.67 0.51 17 3.6 2.9 15 47.5% -2.93 [-4.42, -1.44] 2013
Total (95% Cl) 35 41 100.0% -1.18 [-4.44, 2.08]
Total (95% Cl) 65 100.0% -1.99 [-22.16, 18.17]
Mean
LA OA Mean Difference
MeanSD Weight IV, Fixed, 95% Cl
Mean Difference
IV, Fixed, 95% ClSDTotal Total
Study or Subgroup Mean
Events Total Events Total Weight M-H, Fixed, 95% CI M-H, Fixed, 95% CIYear
Lombardi 2012 1 30 7 126 22.8% 0.59 [0.07, 4.95] 2012
Mir 2013 1 18 5 126 33.9% 0.25 [0.03, 2.32] 2013
Fossa 2013 2 17 3 15 24.7% 0.53 [0.08, 3.72] 2013
Donatini 2014 1 13 3
Total events 5 18
21 18.6% 0.50 [0.05, 5.39]
Total (95% Cl) 78 188 100.0% 0.44 [0.15, 1.30]
2014
LA OA Odds Ratio Odds Ratio
LA OA Mean Difference
MeanSD Weight IV, Random, 95% Cl Year
Mean Difference
IV, Random, 95% ClSDTotal Total
FIG. 2 Forrest and funnel plots for surgical outcomes
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218 remain scanty and controversial outcomes have been
219 reported.12 A recent analysis of the large National Inpatient
220 Sample database has suggested that the use of laparoscopic
221 techniques to perform adrenalectomy has increased at a
222 slower rate over the last decade when compared with other
223 procedures.27
224 The present systematic review and meta-analysis pro-
225 vides the best currently available evidence on the
226 comparative outcomes of laparoscopy versus open surgery
227 for the surgical resection of ACC with the aim of
228determining to what extent a minimally invasive approach
229should be considered in this setting.
230Fewfindings of our analysis are of worth of consideration.
231First and foremost, the fact that a limited number of com-
232parative studies are available, most of them with a limited
233number of cases, especially for the laparoscopic cohorts,
234which reflects the rarity of the disease. Moreover, despite
235being of good quality, all of these studies are retrospective
236case–control series, implying a patient selection bias and
237other intrinsic limitations related to their design.
a. Overall recurrence rate
c. Time to recurrence
d. Cancer specific mortality rate
b. Peritoneal carcinomatosis at recurrence 
Study or Subgroup
Miller 2010
Brix 2010
Porpiglia 2010
Miller 2012
Lombardi 2012
Cooper 2013
Mir 2013
Fossa 2013
Donatini 2014
Miller 2010
Miller 2010
Porpiglia 2010
Brix 2010
Lombardi 2012
Mir 2013 
Cooper 2013
Donatini 2014
1
13
5
10
22
2
18
35
24
18
46
13
7
48
41
20
20
4
53 140
25
117
110
26
46
21
10.6%
27.3%
19.9%
10.8%
23.3%
8.1%
-0.22 [-0.43, -0.02]
-0.04 [-0.22, 0.14]
-0.16 [-0.35, 0.02]
-0.21 [-0.49, 0.07]
0.04 [-0.16, 0.25]
-0.04 [-0.29, 0.22]
154 345 100.0% -0.08 [-0.17, 0.01]
2010
2010
2012
2013
2013
2014
Miller 2012
Mir 2013
Lombardi 2012
19.2
29.5
13.8
27
37.5
5.2
13.8
27
71
110
26
126
9.6
117
9.7
29
14
2.1
9.6
33
17
46
18
30
22.4%
30.5%
26.7%
20.5%
9.60 [-1.37, 20.57]
17.80 [16.65, 18.95]
4.10 [-2.81, 11.01]
-2.00 [-14.71, 10.71]
2010
2012
2013
2012
Brix 2010
Cooper 2013
Fossa 2013
Mir 2013
3
1
25
2
1
17
35
46
17
18
8
4
9
0
0
32 21
71
117
46
15
26
20.8%
12.4%
60.5%
3.6%
2.8%
1.57 [0.46, 5.29]
0.84 [0.10, 7.24]
2.78 [1.46, 5.28]
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FIG. 3 a, b Forrest and funnel plots for oncological outcomes
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238 Nevertheless, the lack of randomized trial is recognized as a
239 common drawback of clinical investigation for any surgical
240 specialty. The two largest studies comparing LA to OA are
241 based on multi-institutional analyses, namely the one
242 reported by the German Adrenocortical Carcinoma Registry
243 Group and the one based on an Italian multi-institutional
244 survey.20,21 In both studies, the ratio open:laparoscopic cases
245 was approximately 3:1, which suggest that in these special-
246 ized centers there has been a selective implementation of
247 laparoscopy. Both studies concluded that oncologic out-
248 comes are not jeopardized if proper patient selection is
249 embraced and principles of oncological radicality are
250 respected.
251 Not surprisingly, we found that patients undergoing OA
252 were on approximately 2.5 years older than those submit-
253 ted to LA (p = 0.005). Moreover, tumors treated with LA
254 are more likely to represent incidental diagnosis
255 (p = 0.002), smaller in size (p\ 0.001), and a localized
256 (I–II) stage compared with OA (p\ 0.001). On the other
257 hand, in six of the nine comparative studies, cases of
258 nonlocalized ACC (stage III–IV) were included,19,20,22–25
259 which can reflect the status of referral centers reporting the
260 studies. Center volume and surgical experience play a
261 crucial role in the oncologic outcome of patients with
262 adrenal malignancies; it has been suggested that adrenal
263 cancer surgery should be performed only in centers with
264 [10 cases per year.28
265 No significant differences could be found in terms of
266 main surgical parameters (operative time, EBL, and com-
267 plication rate) between LA and OA. The lack of significant
268 difference in terms of operative time can be regarded as an
269 unexpected finding especially considering the need for
270 adjacent organ removal that is very time consuming step,
271 and it was probably more extensive in the open surgery
272 cases. To note, the surgical outcome ‘‘operative time’’
273 could be retrieved only in one third of the studies included
274 in the meta-analysis. Thus, there might have certainly been
275 a case selection bias. In addition, we could not assess in
276 this setting the impact of the ‘‘learning curve’’ factor. In
277 other words, the surgical experience of the different sur-
278 geons from the different studies might have played a role.
279 Also, when considering that most of these are academic
280 institutions, one can speculate that residents/fellows were
281 involved in portions of the cases, thus impacting the
282 duration of surgery.
283 Hospitalization time was clearly in favor of laparoscopy,
284 with a statistical (p\ 0.001) but also clinically significant
285 difference (WMD of -2.5 days). The concept that
286 laparoscopic surgery shortens hospital stay and likely
287 enables a faster return to normal daily activities has been
288 largely demonstrated for a variety of urologic diseases.29
289 The importance of complete, en bloc, margin-negative
290 resection of ACC in patients who are fit to undergo surgery
291is a consolidated principle. In a large analysis from the
292national cancer database, Bilimoria et al. showed that
293median survival for patients with margin-negative resec-
294tion was 51.2 months, whereas it was only 7 months for
295those who underwent margin positive resection.30 We
296found no difference in the rate of negative surgical mar-
297gins, which was reported in seven of the studies (61.9 %
298for LA, 57.6 % for OA; p = 0.98).19,20,22–26
299The aggressive behavior of ACC provided the rationale
300for the use of adjuvant therapy, either radiotherapy to the
301tumor bed or mitotane.31 We found that adjuvant therapy
302(any form) was used in a similar proportion of cases for LA
303and OA (32.5 and 29.8 %, respectively; p = 0.91) 20,21,23,25;
304however, this finding is difficult to interpreter as different
305Centers might have adopted different therapeutic criteria.
306In the only available meta-analysis of studies comparing
307LA versus OA for ACC, Sgourakis et al. looked at the
308oncological outcomes for stage I/II disease.32 They inclu-
309ded four comparative studies, all of them also included in
310our meta-analysis.18,21,24,26 The authors found that OA
311seems to provide better survival rates at 5 years. This
312finding resembles those reported by Miller et al., who
313reviewed the single-institution experience with the surgical
314treatment of 217 cases of ACC (stage I–III).19 Overall
315survival for patients with stage II cancer was longer in
316those undergoing OA. Moreover, time to local or peritoneal
317recurrence was shorter in those treated laparoscopically.
318We could not find differences for most relevant onco-
319logical outcomes between LA and OA, namely the overall
320recurrence rate (p = 0.53), time to recurrence (p = 0.11),
321and cancer-specific mortality (p = 0.08). However, there
322was a higher risk of development of peritoneal carcino-
323matosis at the time of recurrence for LA (RR 2.39; CI 1.41,
3244.04; p = 0.001). This finding is in line with the study by
325Leboulleux et al., who found the surgical approach to be
326related to the risk of peritoneal carcinomatosis,33 as well as
327data reported by Gonzalez et al. who observed peritoneal
328carcinomatosis in 5 of the 6 patients (83 %) who under-
329went laparoscopic resection of ACC in their series.10
330Considering that patients with ACC recurrence seem to
331have higher survival rates if amenable to complete surgical
332resection and the presence of peritoneal recurrence is likely
333to compromise a salvage surgery, these findings support the
334concept that a complete oncological resection remains the
335key factor, and it should not be compromised by the
336implementation of a minimally invasive approach.
337The major limitation of this meta-analysis is related to
338the retrospective design of included studies, which allowed
339the analysis to be necessarily limited to certain parameters.
340Thus, it was not possible to perform a more detailed sep-
341arate analysis of oncological outcomes (local recurrence
342only versus distant recurrence only versus peritoneal car-
343cinomatosis only versus a combination of these events).
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344 Similarly, it was not possible to weight the impact of the
345 different forms of adjuvant therapy used in the different
346 studies. Moreover, it is not possible to account for existing
347 differences among centers in terms of surgical techniques,
348 as well as protocols of perioperative management and
349 oncological follow-up. Despite these limitations, we are
350 able to provide the best available evidence in the field, as
351 nine studies with more than 700 ACC cases were included
352 in the analysis. Thus, our findings can be used as reference
353 for further clinical investigation.
354 Last, the role of robot-assisted laparoscopy in this set-
355 ting remains to be determined. Robot-assisted laparoscopy
356 is being implemented for adrenal surgery and recent evi-
357 dence suggests that robotic adrenalectomy can be
358 performed safely and effectively with potential advantages
359 of a shorter hospital stay, less blood loss, and lower
360 occurrence of postoperative complications.7 Data on the
361 use of robotics for large adrenal masses remain scanty, but
362 early series are encouraging.34
363 CONCLUSIONS
364 OA should be still considered the standard for the sur-
365 gical management of ACC, as it allows proper radical
366 extirpation of the disease. LA can offer a shorter hospital
367 stay, possibly allowing a quicker postoperative recovery,
368 and it can certainly have a complementary role in this
369 setting. However, this minimally invasive approach should
370 be only offered in carefully selected ACC cases and by
371 centers with appropriate laparoscopic expertise in order to
372 avoid jeopardizing the oncological outcome.
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